Interestingly, this segment is also indispensable for binding to FASN, a process that contributes to alleviating MAFLD.[22] Targeting this amino acid segment with small molecules may offer therapeutic potential for a wide range of metabolic diseases. The gene discussed is FASN; the disease is Other metabolic disease.